The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCOLADE INC | COM | 00437E102 | 56,578,460 | 5,398,708 | SH | SOLE | 5,398,708 | 0 | 0 | ||
BLOCK INC | CL A | 852234103 | 85,992,232 | 1,016,697 | SH | SOLE | 1,016,697 | 0 | 0 | ||
CYNGN INC | COM | 23257B107 | 870,028 | 5,234,828 | SH | SOLE | 5,234,828 | 0 | 0 | ||
DOORDASH INC | CL A | 25809K105 | 219,940,217 | 1,597,010 | SH | SOLE | 1,597,010 | 0 | 0 | ||
ERASCA INC | COM | 29479A108 | 5,896,750 | 2,862,500 | SH | SOLE | 2,862,500 | 0 | 0 | ||
GINKGO BIOWORKS HOLDINGS INC | CL A SHS | 37611X100 | 5,037,589 | 4,342,749 | SH | SOLE | 4,342,749 | 0 | 0 | ||
MAPLEBEAR INC | COM | 565394103 | 313,466,751 | 8,406,188 | SH | SOLE | 8,406,188 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 51,902,516 | 17,653,917 | SH | SOLE | 17,653,917 | 0 | 0 | ||
OPENDOOR TECHNOLOGIES INC | COM | 683712103 | 20,416,170 | 6,738,010 | SH | SOLE | 6,738,010 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 88,584,896 | 2,748,523 | SH | SOLE | 2,748,523 | 0 | 0 | ||
ROBINHOOD MKTS INC | COM CL A | 770700102 | 381,561,332 | 18,954,860 | SH | SOLE | 18,954,860 | 0 | 0 | ||
SAMSARA INC | COM CL A | 79589L106 | 150,995,689 | 3,995,652 | SH | SOLE | 3,995,652 | 0 | 0 | ||
SHAPEWAYS HOLDINGS INC | COM NEW | 81947T201 | 1,184,044 | 598,002 | SH | SOLE | 598,002 | 0 | 0 |